Sunny 92.3 will air live from Children’s Hospital at Erlanger and Hamilton Place Mall during the 6th Annual Cure Kids Cancer Radiothon Dec. 10-15.
During the event, patients and their families, along with physicians, nurses, and staff members hope, to bring awareness of the Center for Childhood Cancer and Blood Disorders, as well as encourage listeners to help make a difference in the lives of the children treated at the hospital.
Sunny 92.3 will broadcast live from 5-9 a.m., Monday, Dec. 10, through Friday, Dec. 14, from Children’s Hospital and on Saturday, Dec. 15, from 10 a.m. until 3 p.m. Kim Carson and James Howard will be live at the Hamilton Place Mall Center Court. Organizers are proud to announce Sara Carr, 18, of Chattanooga, will also entertain shoppers with a special vocal performance on Saturday. Sara received treatment at Children’s Hospital for Diffuse Large Cell Lymphoma and is now representing the hospital as one of the 2013 Miracle Children.
Listeners can access the radiothon at 92.3 or online at www.sunny923.com and will hear first-hand from the many families who have benefited from the center’s treatment and care. The radiothon will feature interviews with oncology patients and families who are currently undergoing treatment at the hospital, those who have undergone treatment in the past, as well as interviews with the medical staff who care for these children every day.
Donations will be accepted by calling 1-877-335-KIDS (5437) or by going to www.erlangerfoundations.org during the radiothon.
All funds raised during the Cure Kids Cancer Radiothon will be used to support cancer research, care and education at the Childhood Cancer and Blood Disorders Center located at Children’s Hospital at Erlanger. The oncology program at Children’s Hospital, the only facility in the region specifically trained to provide cancer care to children and young adults, is part of a national network of children’s hospitals called Children’s Oncology Group. This group meets regularly to share information on childhood cancer and standardize protocols.